These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11448070)

  • 1. Brain perfusion SPECT study with 99mTc-bicisate: clinical pitfalls and improved diagnostic accuracy with a combination of linearization and scatter-attenuation correction.
    Kado H; Iida H; Kimura H; Ogawa T; Narita Y; Hatazawa J; Tsuchida T; Yonekura Y; Itoh H
    Ann Nucl Med; 2001 Apr; 15(2):123-9. PubMed ID: 11448070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain perfusion SPECT with 99mTc-bicisate: comparison with PET measurement and linearization based on permeability-surface area product model.
    Yonekura Y; Tsuchida T; Sadato N; Nishizawa S; Iwasaki Y; Mukai T; Konishi J; Shibasaki H
    J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S58-65. PubMed ID: 8263073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetazolamide challenge and technetium-99m-ECD versus iodine-123-IMP SPECT in chronic occlusive cerebrovascular disease.
    Ohnishi T; Yano T; Nakano S; Jinnouchi S; Nagamachi S; Flores LI; Nakahara H; Watanabe K
    J Nucl Med; 1997 Sep; 38(9):1463-7. PubMed ID: 9293809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant 99mTc-ECD images of CBF in patients with subacute cerebral infarction: a comparison of CBF, CMRO2 and 99mTc-HMPAO imaging.
    Shishido F; Uemura K; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Nagata K
    Ann Nucl Med; 1995 Aug; 9(3):161-6. PubMed ID: 8534592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral uptake of 99mTc-bicisate in patients with cerebrovascular disease in comparison with CBF and CMRO2 measured by positron emission tomography.
    Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Kanno I; Aizawa Y; Nagata K
    J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S66-75. PubMed ID: 8263074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction: comparison with 133Xe SPECT.
    Ogasawara K; Ogawa A; Ezura M; Konno H; Doi M; Kuroda K; Yoshimoto T
    J Nucl Med; 2001 Apr; 42(4):543-7. PubMed ID: 11337539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scatter and attenuation correction in technetium-99m brain SPECT.
    Hashimoto J; Kubo A; Ogawa K; Amano T; Fukuuchi Y; Motomura N; Ichihara T
    J Nucl Med; 1997 Jan; 38(1):157-62. PubMed ID: 8998171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of scatter and attenuation correction on quantitative assessment of regional cerebral blood flow with SPECT.
    Iida H; Narita Y; Kado H; Kashikura A; Sugawara S; Shoji Y; Kinoshita T; Ogawa T; Eberl S
    J Nucl Med; 1998 Jan; 39(1):181-9. PubMed ID: 9443759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective clinical comparison of non-corrected and attenuation- and scatter-corrected myocardial perfusion SPECT in patients with suspicion of coronary artery disease.
    Banzo I; Pena FJ; Allende RH; Quirce R; Carril JM
    Nucl Med Commun; 2003 Sep; 24(9):995-1002. PubMed ID: 12960599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improvement in accuracy of quantitative assessment of the regional cerebral blood flow with 99mTc-ECD].
    Takaki A; Yoshioka K; Teraoka S; Souma T; Okada K; Yokoi T; Murase K
    Kaku Igaku; 2005 Feb; 42(1):11-6. PubMed ID: 15794117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
    Tsuchida T; Nishizawa S; Yonekura Y; Sadato N; Iwasaki Y; Fujita T; Matoba N; Magata Y; Tamaki N; Konishi J
    J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of scatter correction on regional distribution of cerebral blood flow using I-123-IMP and SPECT.
    Ito H; Iida H; Kinoshita T; Hatazawa J; Okudera T; Uemura K
    Ann Nucl Med; 1999 Oct; 13(5):331-6. PubMed ID: 10582803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET].
    Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Higano S; Fujita H; Shimosegawa E; Kanno I; Aizawa Y
    Kaku Igaku; 1992 Jan; 29(1):27-35. PubMed ID: 1578819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technetium-99m-ECD brain SPECT in misery perfusion.
    Shimosegawa E; Hatazawa J; Aizawa Y; Shouji Y; Hachiya T; Murakami M
    J Nucl Med; 1997 May; 38(5):791-6. PubMed ID: 9170448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multi-center study for the evaluation of clinical usefulness of attenuation and scatter correction on 201Tl myocardial SPECT].
    Tomiguchi S; Kumita S; Hashimoto J; Inoue T; Nomura Y; Emoto J; Nakajima K; Nishimura T
    Kaku Igaku; 2002 Feb; 39(1):37-46. PubMed ID: 11915311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Brain 99mTc-Ethyl Cysteinate Dimer SPECT Imaging and Analysis to Detect Misery Perfusion on 15O PET Imaging in Patients With Chronic Occlusive Disease of Unilateral Major Cerebral Artery.
    Matsumoto Y; Oikawa K; Nomura JI; Kojima D; Oshida S; Kobayashi M; Terasaki K; Kubo Y; Ogasawara K
    Clin Nucl Med; 2017 Jul; 42(7):499-505. PubMed ID: 28481786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT nonuniform attenuation and TEW scatter corrections in brain Tc-99m ECD SPECT.
    Farid K; Habert MO; Martineau A; Caillat-Vigneron N; Sibon I
    Clin Nucl Med; 2011 Aug; 36(8):665-8. PubMed ID: 21716017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-bicisate reliably images CBF in chronic brain diseases but fails to show reflow hyperemia in subacute stroke: report of a multicenter trial of 105 cases comparing 133Xe and 99mTc-bicisate (ECD, neurolite) measured by SPECT on same day.
    Lassen NA; Sperling B
    J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S44-8. PubMed ID: 8263071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
    Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H
    J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.